不同发育潜能人类胚胎的全基因组DNA甲基化图谱评估
研究对30个囊胚的滋养外胚层活检样本行全基因组亚硫酸氢盐测序,比较非整倍体与整倍体、母体年龄及囊胚形成时间的甲基化差异。结果显示非整倍体胚胎全基因组甲基化水平高于整倍体,且甲基化水平随母体年龄升高,提示全基因组甲基化水平可能与胚胎质量负相关。
要点
- 非整倍体胚胎滋养外胚层全基因组甲基化水平高于整倍体胚胎。
- 全基因组DNA甲基化水平随母体年龄增加而升高。
- 全基因组亚硫酸氢盐测序可精确揭示染色体拷贝数变异。
核心结论
- 滋养外胚层全基因组甲基化谱与胚胎整倍体状态及母体年龄相关,全基因组甲基化水平可能与胚胎质量负相关。
研究设计与样本
- 研究收集30个随机选择的人类囊胚的滋养外胚层活检样本,行全基因组亚硫酸氢盐测序评估DNA甲基化谱。
- 采用嵌套线性模型评估甲基化水平与倍性状态(非整倍体n=20 vs 整倍体n=10)、母体年龄(29.4-42.5岁)及囊胚形成时间(第5天n=16 vs 第6天n=14)的关联,以胚胎身份为协变量。
主要发现
- 非整倍体胚胎滋养外胚层活检全基因组DNA甲基化水平较整倍体胚胎升高(25.4% ± 3.2% vs. 24.7% ± 3.2%,P < 0.005)。
- 全基因组DNA甲基化水平随母体年龄增加而升高(P < 0.005)。
- 在染色体尺度上,单体胚胎所涉及染色体甲基化水平较低,而三体所涉及染色体未见剧烈变化。
- 全基因组亚硫酸氢盐测序数据可精确揭示染色体拷贝数变异。
临床怎么用
- 全基因组甲基化水平与胚胎质量负相关,但用于评估胚胎潜能前需在更多胚胎中进一步行全基因组亚硫酸氢盐测序分析,并明确其与着床及活产的相关性。
局限性
- 结果提示全基因组甲基化水平与胚胎质量负相关,但实际用于评估胚胎潜能前需扩大样本行全基因组亚硫酸氢盐测序分析,并专门研究其与着床和活产的相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do embryos with different developmental competence exhibit different DNA methylation profiles at the blastocyst stage? SUMMARY ANSWER: We established genome-wide DNA methylome analysis for embryo trophectoderm (TE) biopsy samples and our findings demonstrated correlation of methylation profile of trophectoderm with euploidy status and with maternal age, indicating that genome-wide methylation level might be negatively correlated with embryo quality. WHAT IS KNOWN ALREADY: DNA methylation is a fundamental epigenetic regulatory mechanism that affects differentiation of cells into their future lineages during pre-implantation embryo development. Currently there is no established approach available to assess the epigenetic status of the human preimplantation embryo during routine IVF treatment. STUDY DESIGN, SIZE, DURATION: In total, we collected trophectoderm biopsy samples from 30 randomly selected human blastocysts and conducted whole-genome bisulfite sequencing (WGBS) to evaluate their DNA methylation profile. Nested linear models were used to assess association between DNA methylation level and ploidy status (aneuploidy [n = 20] vs. euploidy [n = 10]), maternal age (29.4-42.5 years old), and time of blastulation (day 5 [n = 16] vs. day 6 [n = 14]), using embryo identity as a covariate. PARTICIPANTS/MATERIALS, SETTING, METHODS: TE biopsy samples were obtained and submitted to bisulfite conversion. For WGBS, whole-genome sequencing libraries were then generated from the converted genome. An average of 75 million reads were obtained for each sample, and about 63% of the reads aligned to human reference. An average of 40 million reads used for the final analysis after the unconverted reads were filtered out. MAIN RESULTS AND THE ROLE OF CHANCE: We revealed an increase of genome-wide DNA methylation level in aneuploid embryo TE biopsies compared to euploid embryos (25.4% ± 3.2% vs. 24.7% ± 3.2%, P < 0.005). We also found genome-wide DNA methylation level to be increased with the maternal age (P < 0.005). On a chromosomal scale, we found monosomic embryos have lower methylation levels on the involved chromosome while no drastic change was observed for the involved chromosome in trisomies. Additionally, we revealed that WGBS data precisely revealed the chromosome copy number variance. LIMITATIONS, REASONS FOR CAUTION: Though our results demonstrated a negative correlation of genome-wide methylation level and embryo quality, further WGBS analysis on a greater number of embryos and specific investigation of its correlation with implantation and live birth are needed before any practical use of this approach for evaluation of embryo competence. WIDER IMPLICATIONS OF THE FINDINGS: This study revealed a change in genome-wide DNA methylation profile among embryos with different developmental potentials, reinforcing the critical role of DNA methylation in early development. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received for this study. Intramural funding was provided by the Foundation for Embryonic Competence (FEC). E.S. is a consultant for and receives research funding from the Foundation for Embryonic Competence; he is also co-founder and a shareholder of ACIS LLC and coholds patent US2019/055906 issued for utilizing electrical resistance measurement for assessing cell viability and cell membrane piercing. TRIAL REGISTRATION NUMBER: N/A.
引用
- Yang M, Tao X, Scott K, et al. Evaluation of genome-wide DNA methylation profile of human embryos with different developmental competences. Hum Reprod. 2021. PMID: 33846747. doi:10.1093/humrep/deab074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。